Advisornet Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.3K | Buy |
697
+137
| +24% | +$4.98K | ﹤0.01% | 1180 |
|
|
2025
Q1 | $20.3K | Buy |
+560
| New | +$20.3K | ﹤0.01% | 1168 |
|
|
2023
Q3 | – | Sell |
-1,500
| Closed | -$69.2K | – | 2390 |
|
|
2023
Q2 | $69.2K | Hold |
1,500
| – | – | 0.01% | 736 |
|
|
2023
Q1 | $60.2K | Hold |
1,500
| – | – | 0.01% | 747 |
|
|
2022
Q4 | $69.5K | Hold |
1,500
| – | – | 0.01% | 714 |
|
|
2022
Q3 | $62K | Hold |
1,500
| – | – | 0.01% | 790 |
|
|
2022
Q2 | $89K | Hold |
1,500
| – | – | 0.01% | 702 |
|
|
2022
Q1 | $109K | Hold |
1,500
| – | – | 0.01% | 719 |
|
|
2021
Q4 | $126K | Hold |
1,500
| – | – | 0.01% | 712 |
|
|
2021
Q3 | $135K | Hold |
1,500
| – | – | 0.01% | 687 |
|
|
2021
Q2 | $143K | Hold |
1,500
| – | – | 0.01% | 681 |
|
|
2021
Q1 | $171K | Hold |
1,500
| – | – | 0.01% | 594 |
|
|
2020
Q4 | $208K | Hold |
1,500
| – | – | 0.02% | 494 |
|
|
2020
Q3 | $123K | Hold |
1,500
| – | – | 0.01% | 617 |
|
|
2020
Q2 | $117K | Hold |
1,500
| – | – | 0.01% | 626 |
|
|
2020
Q1 | $67K | Hold |
1,500
| – | – | 0.01% | 706 |
|
|
2019
Q4 | $64K | Sell |
1,500
-1,350
| -47% | -$57.6K | 0.01% | 809 |
|
|
2019
Q3 | $122K | Hold |
2,850
| – | – | 0.01% | 618 |
|
|
2019
Q2 | $181K | Hold |
2,850
| – | – | 0.02% | 468 |
|
|
2019
Q1 | $198K | Hold |
2,850
| – | – | 0.02% | 430 |
|
|
2018
Q4 | $124K | Buy |
2,850
+650
| +30% | +$28.3K | 0.02% | 473 |
|
|
2018
Q3 | $168K | Hold |
2,200
| – | – | 0.02% | 451 |
|
|
2018
Q2 | $169K | Hold |
2,200
| – | – | 0.02% | 427 |
|
|
2018
Q1 | $112K | Hold |
2,200
| – | – | 0.02% | 504 |
|
|
2017
Q4 | $102K | Buy |
+2,200
| New | +$102K | 0.02% | 478 |
|